Healthcare provider profile · identity verified

Kevin Lee Bogar, M.D.

Internal Medicine · GARFIELD HEIGHTS, OH · NPI 1912908724

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	839	251
Amlodipine Besylate	Amlodipine Besylate	582	176
Levothyroxine Sodium	Levothyroxine Sodium	352	113
Rosuvastatin Calcium	Rosuvastatin Calcium	342	108
Lisinopril	Lisinopril	337	102
Metformin Hcl	Metformin Hcl	329	105
Gabapentin	Gabapentin	320	86
Metoprolol Succinate	Metoprolol Succinate	298	99
Metoprolol Tartrate	Metoprolol Tartrate	281	79
Losartan Potassium	Losartan Potassium	270	89
Pantoprazole Sodium	Pantoprazole Sodium	263	77
Eliquis	Apixaban	202	51
Omeprazole	Omeprazole	197	70
Furosemide	Furosemide	196	63
Potassium Chloride	Potassium Chloride	190	63
Simvastatin	Simvastatin	184	56
Tramadol Hcl	Tramadol Hcl	174	39
Albuterol Sulfate Hfa	Albuterol Sulfate	165	54
Carvedilol	Carvedilol	165	31
Duloxetine Hcl	Duloxetine Hcl	131	35
Allopurinol	Allopurinol	126	45
Clopidogrel	Clopidogrel Bisulfate	126	41
Jardiance	Empagliflozin	124	35
Alprazolam	Alprazolam	116	34
Atenolol	Atenolol	114	42
Montelukast Sodium	Montelukast Sodium	111	37
Ozempic	Semaglutide	111	21
Trazodone Hcl	Trazodone Hcl	111	33
Hydrochlorothiazide	Hydrochlorothiazide	102	41
Famotidine	Famotidine	99	44
Prednisone	Prednisone	98	46
Tamsulosin Hcl	Tamsulosin Hcl	97	29
Tizanidine Hcl	Tizanidine Hcl	91	35
Escitalopram Oxalate	Escitalopram Oxalate	88	25
Lorazepam	Lorazepam	86	30
Fluticasone Propionate	Fluticasone Propionate	79	27
Glimepiride	Glimepiride	78	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	23
Donepezil Hcl	Donepezil Hcl	77	22
Clonazepam	Clonazepam	73	17
Januvia	Sitagliptin Phosphate	72	12
Zolpidem Tartrate	Zolpidem Tartrate	71	17
Synthroid	Levothyroxine Sodium	70	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	19
Mirtazapine	Mirtazapine	67	18
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	66	20
Spironolactone	Spironolactone	66	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	65	21
Sertraline Hcl	Sertraline Hcl	64	20
Torsemide	Torsemide	64	21
Warfarin Sodium	Warfarin Sodium	64	25
Mounjaro	Tirzepatide	63	15
Paroxetine Hcl	Paroxetine Hcl	63	15
Cephalexin	Cephalexin	61	45
Hydralazine Hcl	Hydralazine Hcl	60	18
Metformin Hcl Er	Metformin Hcl	59	22
Quetiapine Fumarate	Quetiapine Fumarate	59	13
Doxazosin Mesylate	Doxazosin Mesylate	54	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	15
Naproxen	Naproxen	52	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	11
Celecoxib	Celecoxib	48	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	15
Pregabalin	Pregabalin	48	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Trulicity	Dulaglutide	47	12
Pravastatin Sodium	Pravastatin Sodium	46	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	14
Olmesartan Medoxomil	Olmesartan Medoxomil	44	11
Buspirone Hcl	Buspirone Hcl	43	16
Methocarbamol	Methocarbamol	43	12
Oxybutynin Chloride Er	Oxybutynin Chloride	43	11
Xarelto	Rivaroxaban	42	suppressed
Bupropion Xl	Bupropion Hcl	41	11
Propranolol Hcl	Propranolol Hcl	41	12
Glipizide	Glipizide	40	13
Oxycodone Hcl	Oxycodone Hcl	39	15
Azithromycin	Azithromycin	37	27
Methotrexate	Methotrexate Sodium	35	suppressed
Valsartan	Valsartan	35	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Ezetimibe	Ezetimibe	33	13
Meclizine Hcl	Meclizine Hcl	33	11
Citalopram Hbr	Citalopram Hydrobromide	32	13
Hydroxyzine Hcl	Hydroxyzine Hcl	31	23
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	15
Esomeprazole Magnesium	Esomeprazole Magnesium	29	11
Benazepril Hcl	Benazepril Hcl	28	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	28	16
Methylprednisolone	Methylprednisolone	28	23
Nifedipine Er	Nifedipine	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Amoxicillin	Amoxicillin	27	11
Ibuprofen	Ibuprofen	27	12
Meloxicam	Meloxicam	27	13
Nitroglycerin	Nitroglycerin	27	16
Nystatin	Nystatin	27	16
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Chlorthalidone	Chlorthalidone	26	11
Diazepam	Diazepam	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Ramipril	Ramipril	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Topiramate	Topiramate	23	11
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Finasteride	Finasteride	22	suppressed
Levofloxacin	Levofloxacin	22	20
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	12
Ondansetron Odt	Ondansetron	20	suppressed
Temazepam	Temazepam	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Jantoven	Warfarin Sodium	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Rivastigmine	Rivastigmine	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Zenpep	Lipase/Protease/Amylase	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Linzess	Linaclotide	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Letrozole	Letrozole	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	12
Digoxin	Digoxin	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Risperidone	Risperidone	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Methimazole	Methimazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error